Ap­ply­ing CRISPR to Duchenne, Duke re­searchers spot­light 1-year mouse da­ta in Sarep­ta-spon­sored study

As Sarep­ta hus­tles its gene ther­a­py for Duchenne mus­cu­lar dy­s­tro­phy in­to a piv­otal study, one of its aca­d­e­m­ic col­lab­o­ra­tors has some longterm mouse da­ta to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER